Lowenstein Sandler represented Catalyst Investors on the transaction. Tava Health, Inc., a provider of virtual mental health and telehealth services to therapists and employee assistance programs,...
Tava Health’s $20 Million Series B Funding Round
First Wave BioPharma’s Acquisition of ImmunogenX
Lowenstein represented First Wave BioPharma, Inc. in the transaction. First Wave BioPharma, Inc. (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic...
Timber Pharmaceuticals’ Chapter 11 and Asset Sale to Leo Pharma
Lowenstein Sandler represented Timber Pharmaceuticals, Inc. in the transaction. Timber Pharmaceuticals, Inc. (NYSE: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for...
Big Health’s Acquisition of Limbix
Lowenstein Sandler represented Big Health in the transaction. Big Health, the leading provider of non-drug digital treatments for mental health, announced the acquisition of Limbix, creators...
Tonix Pharmaceuticals’ $25 Million Acquisition of FDA-Approved Products from Upsher-Smith Laboratories
Lowenstein represented Tonix Pharmaceuticals Holding Corp. in the transaction. Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a clinical-stage biopharmaceutical company, announced its $25 million acquisition of two...
Traub Capital’s Investment in Sabatino Tartufi
Lowenstein Sandler represented Traub Capital Partners in the transaction. Traub Capital Partners, a strategic private equity firm specializing in building value in consumer companies using its...
Coya Therapeutics’ $15.25 Million Initial Public Offering
Lowenstein Sandler represented Coya Therapeutics in the transaction. Coya Therapeutics, Inc. (Nasdaq: COYA), a clinical-stage biotechnology company developing proprietary therapies to enhance the function of regulatory...
LTS Lohmann Therapy Systems’ Acquisition of Tapemark
Lowenstein Sandler represented LTS Lohmann Therapy Systems, Corp. in the transaction. LTS Lohmann Therapy Systems, Corp. (“LTS”) executed its acquisition of Tapemark Inc. (“Tapemark”) located in...
Crown Laboratories’ Acquisition of Eclipse MedCorp’s Assets
Lowenstein Sandler represented Crown Laboratories in the transaction. Crown Laboratories, Inc. (“Crown”), a leading, fully integrated global skincare company, announced its agreement with Eclipse MedCorp LLC,...
Signature Brands’ Acquisition of Brand Castle
Lowenstein Sandler represented Signature Brands and its owner Traub Capital Partners in the transaction. Signature Brands, the leading North American manufacturer of dessert decorating products, announced...
Crown Laboratories’ Acquisition of StriVectin
Lowenstein advised Hildred Capital Management and Crown Laboratories on the deal, while Gibson, Dunn & Crutcher advised StriVectin and L Catterton. Hildred Capital Management (Hildred) and...
Halma’s Acquisition of PeriGen
Lowenstein Sandler represents PeriGen Inc. in the transaction. Halma plc executed the acquisition of PeriGen Inc. (PeriGen), a leading provider of perinatal health care software solutions. PeriGen’s...